Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults
CITATION: Gbabe, O. F. et al. 2014. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults. Cochrane Database of Systematic Reviews, 9: CD003256, doi:10.1002/14651858.CD003256.pub2.
The original publication is available at https://www.cochranelibrary.com
Background: Kaposi’s sarcoma remains the most common cancer in Sub-Saharan Africa and the second most common cancer in HIV-infected patients worldwide. Since the introduction of highly active antiretroviral therapy (HAART), there has been a decline in its incidence. However, Kaposi’s sarcoma continues to be diagnosed in HIV-infected patients. Objectives: To assess the added advantage of chemotherapy plusHAART compared toHAART alone; and the advantages of different chemotherapy regimens in HAART and HAART naive HIV infected adults with severe or progressive Kaposi’s sarcoma.